CRYCY yields 5.41% · PFE yields 6.20%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, CRYCY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CRYCY + PFE for your $10,000?
China Railway Signal & Communication Corporation Limited, together with its subsidiaries, provides rail transportation control system solutions in China and internationally. It operates through three segments: Rail Transportation Control System, General Engineering Contracting, and Others. The company offers design, consultancy, and system integration services for rail transportation control system projects. It also produces and sells signal system products, communication information system products, infrastructure equipment and information systems, and other related products. In addition, the company offers construction, installation, testing, operation, and maintenance services for rail transportation control systems; and services relating to municipal engineering projects and other construction projects. Further, it engages in the investment management, technical exchange and trade, and bidding agency activities, as well as provision of project management activities. The company was founded in 1953 and is headquartered in Beijing, China. China Railway Signal & Communication Corporation Limited is a subsidiary of China Railway Signal & Communication (Group) Corporation Limited.
Full CRYCY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.